Left atrial appendage exclusion using a stapler with thoracoscopic ablation of atrial fibrillation

Highlights. Stroke prevention in patients with atrial fibrillation is extremely important and difficult. Lifelong anticoagulant therapy is not always an effective way of preventing thrombosis in the left atrial appendage in this group of patients. In this regard, one of the most urgent problems of modern surgical arrhythmology and cardiac surgery is the search for new open and minimally invasive surgical methods of excluding the left atrial appendage from the blood flow.

Aim. To investigate the safety and efficacy of using the left atrial appendage stapler for video-guided thoracoscopic ablation (TSA) of non-valvular atrial fibrillation (AF).

Methods. The retrospective, single-center study included 100 patients with non-valvular AF who underwent video-guided thoracoscopic ablation of AF with single-stage left atrial appendage exclusion using an Endo GIA stapler (Medtronic, Minneapolis, Minnesota, USA).

Results. The mean age of the patients was 56,2±8,8 years, the majority of the patients (73 patients, 73%) were male. Patients with persistent 50 (50%) AF and longstanding AF 50 (50%) were included in the study. The duration of atrial fibrillation was 4 (1,7–7) years. The median CHA2DS2-VASc and HAS-BLED scores were 2 (1–1,5) and 1 (0-1), respectively. The mean anticoagulation therapy-to-ablation time was 4,2±1,9 years. Thirty-eight (38%) patients were prescribed warfarin preoperatively. The completeness of left atrial appendage (LAA) exclusion was confirmed by intraoperative transesophageal echocardiography. The average length of the staple lines was 48 (35–75). A single left atrial appendage exclusion was performed using a 60 mm staples. In 12 (12%) patients, stapler exclusions were performed using two 45 mm staples due to insufficient staple length. None of the patients had ruptures, punctures along the staple lines or rupture of the surrounding epicardial tissue. Anticoagulant therapy was discontinued 6 months after TSA in 70 (70%) patients with sustained sinus rhythm observed on 24-h Holter Monitoring, satisfactory CHA2DS2-VASc scores and after confirmation of absence of left atrial thrombus by transesophageal echocardiography and contrast-enhanced MSCT. No strokes were reported within 1,2±0,7 years after discontinuing anticoagulation therapy.

Conclusion. Exclusion of LAA using a stapler for TSA is a highly effective and safe technique for patients with non-valvular atrial fibrillation compared to alternative methods of excluding the LAA from the systemic blood flow.

1. Benjamin E.J., Muntner P., Alonso A., et al. Heart disease and stroke Statistics-2019 update: A report from the American Heart Association. Circulation. 2019; 139: e56-528. doi:10.1161/CIR.0000000000000746.

2. Chugh S.S., Havmoeller R., Narayanan K., et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014; 129: 837-47. doi:10.1161/CIRCULATIONAHA.113.005119.

3. Fang M.C., Go A.S., Chang Y., et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2008; 51: 810-5. doi:10.1016/j.jacc.2007.09.065.

4. Kawabata M., Goya M., Maeda S., et al. A survey of direct oral anticoagulant cessation in general surgery and outcomes in patients with nonvalvular atrial fibrillation. Int Heart J. 2020; 61:905-12. doi:10.1536/ihj.19-625.

5. Cresti A., García-Fernández M.A., Sievert H., et al. Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. EuroIntervention. 2019; 15: e225-30. doi:10.4244/EIJ-D-19-00128.

6. Lee R., Vassallo P., Kruse J., et al. A randomized, prospective pilot comparison of 3 atrial appendage elimination techniques: internal ligation, stapled excision, and surgical excision. J Thorac Cardiovasc Surg. 2016; 152: 1075-80. doi:10.1016/j.jtcvs.2016.06.009.

7. Salzberg S.P., Plass A., Emmert M.Y., et al. Left atrial appendage clip occlusion: early clinical results. J Thorac Cardiovasc Surg. 2010; 139: 1269-74. doi:10.1016/j.jtcvs.2009.06.033.

8. Kang Y., Hwang H.Y., Joo S., et al. Left atrial appendage elimination techniques: stapled excision versus internal suture obliteration. J Thorac Dis. 2021 Nov;13(11):6252-6260. doi:10.21037/jtd-21-1138.

9. Vachev S.A., Zotov A.S., Troitskiy A.V. Isolated thoracoscopic left atrial appendage exclusion. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2020;13(3):249 252. (In Russ.) doi:10.17116/kardio202013031249

10. Shilenko P.A., Tsoi M.D., Cherkes A.N., et al. Turnstile left atrial appendage occlusion during thoracoscopic ablation. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2017;10(6):57 60. (In Russ.). doi:10.17116/kardio201710657-60

11. Gillinov A.M., Pettersson G., Cosgrove D.M. Stapled excision of the left atrial appendage. J Thorac Cardiovasc Surg. 2005; 129:679-80. doi:10.1016/j.jtcvs.2004.07.039.

12. Revishvili A.Sh., Kadirova M., Popov V.A., et al. Influence of Left Atrium Volume Index on effectiveness of Thoracoscopic Ablation in the Treatment of Atrial Fibrillation. Medical Visualization. 2022;26(3): 22-33. (In Russ.)]. doi:10.24835/1607-0763-1162.

13. Revishvili A.Sh., Taimasova I.A., Artyukhina E.A., et al. Mid-term outcomes of thoracoscopic and hybrid therapy of atrial fibrillation. Journal of Arrhythmology. 2021;28(3): 5-12. (In Russ.) doi: 10.35336/VA-2021-3-5-12.

14. Hindricks G., Potpara T., Dagres N., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42: 373-498. doi:10.1093/eurheartj/ehaa945.

15. Hindricks G., Potpara T., Dagres N., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Rus Card J. 2021; 42: 373-498. (In Russ.) doi:10.1093/eurheartj/ehaa945.

16. Badhwar V., Rankin J.S., Damiano R.J., et al. The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg. 2017;103: 329–41. doi:10.1016/j.athoracsur.2016.10.076.

17. Whitlock R., Healey J., Vincent J., et al. Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. Ann Cardiothorac Surg. 2014 Jan;3(1):45-54. doi:10.3978/j.issn.2225-319X.2013.12.06.

18. Katz E.S., Tsiamtsiouris T., Applebaum R.M., et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol. 2000; 36: 468-71. doi:10.1016/s0735-1097(00)00765-8.

19. Dar T., Turagam M.K., Yarlagadda B., et al. Indication, Patient Selection, and Referral Pathways for Left Atrial Appendage Closure. Interv Cardiol Clin. 2018;7(2):169-183. doi:10.1016/j.iccl.2017.12.003

20. Holmes D.R., Reddy V.Y., Turi Z.G., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009; 374: 534-42. doi:10.1016/S0140-6736(09)61343-X.

21. Holmes D.R., Doshi S.K., Kar S., et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2015; 65: 2614-23. doi:10.1016/j.jacc.2015.04.025.

22. Healey J.S., Crystal E., Lamy A., et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005;150: 288-93. doi:10.1016/j.ahj.2004.09.054.

23. Ailawadi G., Gerdisch M.W., Harvey R.L., et al. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg. 2011; 142: 1002-9. doi:10.1016/j.jtcvs.2011.07.052.

24. Ellis C.R., Aznaurov S.G., Patel N.J., et al. Angiographic efficacy of the Atriclip left atrial appendage exclusion device placed by minimally invasive thoracoscopic approach. JACC Clin Electrophysiol. 2017; 3: 1356-65. doi:10.1016/j.jacep.2017.03.008.

25. Osmancik P., Budera P., Zdarska J., et al. Residual echocardiographic and computed tomography findings after thoracoscopic occlusion of the left atrial appendage using the AtriClip PRO device. Interact Cardiovasc Thorac Surg. 2018;26(6):919-925. doi:10.1093/icvts/ivx427.